<qa>  What is the name of the TKIs?8. No prior therapy for locally recurrent or metastatic disease with TKIs RASRaf, MEK, AKT, mTOR inhibitors and angiogenesis inhibitors VEGVVEGFR, PDGFPDGFR but bevacizumab will be allowed. 